Engineered Pluronic Nanomicelles Target TNBC Differentiation
In a groundbreaking advancement that could revolutionize treatment paradigms for triple-negative breast cancer (TNBC), researchers have unveiled a novel nanotechnology-based therapeutic platform. By engineering pluronic...















